Involvement of p27(Kip1) in the G1- and S/G2-phase lengthening mediated by glucocorticoids in normal human lymphocytes

Cell Growth and Differentiation

Volumn 10, Issue 6, 1999, Pages 405-412

  Baghdassarian, Nathalie ^b   Peiretti, Alexandra ^b   Devaux, Elwire ^b   Bryon, Paul André ^a,b   Ffrench, Marline ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; DACTINOMYCIN; DEXAMETHASONE; INTERLEUKIN 2; PROTEIN P27; CDK2 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GLUCOCORTICOID; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; TRANSLATION REGULATION; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; LYMPHOCYTE; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS;

CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DEXAMETHASONE; ENZYME ACTIVATION; G1 PHASE; G2 PHASE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; LYMPHOCYTES; MICROTUBULE-ASSOCIATED PROTEINS; MITOGENS; PHYTOHEMAGGLUTININS; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; S PHASE; TUMOR SUPPRESSOR PROTEINS;

EID: 0032587146     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.), 284: 555-556, 1980.
2. Ernst, P., and Killmann, S. A. Perturbation of generation cycle of human leukemic blast cells by cytostatic therapy in vivo: effect of corticosteroids. Blood, 36: 689-696, 1970.
3. Rupprecht, R., Wodarz, N., Komhuber, J., Schmitz, B., Wild, K., Braner, H. U., Müller, O. A., and Riederer, P. In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in man: relationship to glucocorticoid receptors. Neuropsychobiology, 24: 61-66, 1990.
4. Fagot, D., Buquet-Fagot, C., and Mester, J. Antimitogenic effects of dexamethasone in chemically transformed mouse fibroblasts. Endocrinology, 129: 1033-1041, 1991.
5. 3 cell cycle. J. Steroid Biochem., 28: 345-347, 1987.
6. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
7. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
8. Kip1) of cyclin-dependent kinase 4 activation. Cell, 79: 487-496, 1994.
9. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev., 10: 142-153, 1996.
10. Firpo, E. J., Koff, A., Solomon, M. J., and Roberts, J. M. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol., 14: 4889-4901, 1994.
11. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (Lond.), 372: 570-573, 1994.
12. Pagano, M., Tarn, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Washington DC), 269: 682-685, 1995.
13. WAF1 is required for surviival of differentiating neuroblastoma cells. Mol. Cell. Biol., 16: 1335-1341, 1996.
14. Kip1 mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem., 272: 7093-7098, 1997.
15. Kip1-deficient mice. Cell, 85: 733-744, 1996.
16. Kip1. Cell, 85: 721-732, 1996.
17. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85: 707-720, 1996.
18. Esposito, V., Baldi, A., De Luca, A., Groger, A. M., Loda, M., Giordano, G. G., Caputi, M., Baldi, F., Pagano, M., and Giordano, A. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res., 57: 3381-3385, 1997.
19. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med., 3: 222-225, 1997.
20. Eastman-Recks, S. B., and Vedeckis, W. V. Glucocorticoid inhibition of c-myc, c-myb, c-ki-ras in a mouse lymphoma cell line. Cancer Res., 46: 2457-2462, 1986.
21. Boumpas, D. T., Anastassiou, E. D., Older, S. A., Tsokos, G. C., Nelson, D. L., and Balow, J. E. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest., 87: 1739-1747, 1991.
22. 1 cyclin-dependent kinase genes in lymphoid cells. Cell Growth Differ., 6: 691-698, 1995.
23. Reisman, D., and Thompson, E. A. Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells. Mol. Endocrinol., 9: 1500-1509, 1995.
24. Cip1. Mol. Endocrinol., 11: 577-586, 1997.
25. Corroyer, S., Nabeyrat, E., and Clement, A. Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids. Endocrinology, 138: 3677-3685, 1997.
26. 1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell-cycle regulatory proteins. Exp. Cell Res., 240: 263-273, 1998.
27. Morta, A. O., Draetta, G., Beach, D., and Wang, J. Y. J. Reversible tyrosine phosphorylation of CDC2: dephosphorylation accompanies activation during entry into mitosis. Cell, 58: 193-203, 1989.
28. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
29. Kip1 accumulation during the cell cycle. Science (Washington DC), 271: 1861-1864, 1996.
30. 0 T cells. J. Immunol., 158: 5642-5648, 1997.
31. Rogatsky, I., Trowbridge, J. M., and Garabedian, M. J. Glucocorticoid receptor-mediated cell-cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol. Cell. Biol., 17: 3181-3193, 1997.
32. Kip1 for restriction point control of the fibroblast cell cycle. Science (Washington DC), 272: 877-880, 1996.
33. Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev., 11: 492-503, 1997.
34. Poon, R. Y. C., Toyoshima, H., and Hunter, T. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell, 6: 1197-1213, 1995.
35. Kip1 activates CDC2. J. Biol. Chem., 272: 21669-21672, 1997.
36. Boumpas, D. T., Anastassiou, E. D., Older, S. A., Tsokos, G. C., Nelson, D. L., and Balow, J. E. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest., 87: 1739-1747, 1991.
37. Perrin-Wolff, M., Bertoglio, J., Bressac, B., Bohuon, C., and Pallardy, M. Structure-activity relationships in glucocorticoid-induced apoptosis in T-lymphocytes. Biochem. Pharmacol., 50: 103-110, 1995.
38. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 762: 156-159, 1987.